'899 Reason's for allowance 3-27-13 "The Combo patent"
It has 10 claims:
#10 "The method of claim 1 wherein the HMG-CoA reductase inhibitor comprises rosuvastation, atorvastatin or pravastatin."
It lists all three.
Rosuvatain or Crestor AZN
Atorvastatin or generic Liptor
And now most interestingly, Pravastin. ***Pravastin is marketed outside Japan by Bristol-Myers Squibb. AZN is also been rumored in an acquisition of both Amarin and Bristol-Myers Squibb;)*** "Astra Zeneca who already collaborate on several dibetes treatments with BMS will pay $3.4 billion in cash for the rights on developing Amylin's products"